Interleukin-2 receptor antagonists as induction therapy after heart transplantation: systematic review with meta-analysis of randomized trials

26 Citationer (Scopus)

Abstract

About half of the transplantation centers use induction therapy after heart transplantation. Interleukin-2 receptor antagonists (IL-2Ras) are used increasingly for induction therapy. We conducted a systematic review of randomized trials assessing IL-2Ras.
OriginalsprogEngelsk
TidsskriftJournal of Heart and Lung Transplantation
Vol/bind27
Udgave nummer8
Sider (fra-til)835-42
Antal sider8
ISSN1053-2498
DOI
StatusUdgivet - aug. 2008

Fingeraftryk

Dyk ned i forskningsemnerne om 'Interleukin-2 receptor antagonists as induction therapy after heart transplantation: systematic review with meta-analysis of randomized trials'. Sammen danner de et unikt fingeraftryk.

Citationsformater